Ocular Therapeutix
Stock Forecast, Prediction & Price Target
Ocular Therapeutix Financial Estimates
Ocular Therapeutix Revenue Estimates
Ocular Therapeutix EBITDA Estimates
Ocular Therapeutix Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $43.52M N/A | $51.49M 18.31% | $58.44M 13.49% | Avg: $77.76M Low: $69.67M High: $86.01M avg. 33.05% | Avg: $122.62M Low: $111.89M High: $134.15M avg. 57.68% | Avg: $187.59M Low: $171.18M High: $205.24M avg. 52.98% | Avg: $361.41M Low: $329.78M High: $395.40M avg. 92.65% |
Net Income
% change YoY
| $-10.80M N/A | $-63.42M -487.02% | $-80.73M -27.29% | Avg: $-130.38M Low: $-102.71M High: $-47.07M avg. -61.50% | Avg: $-93.99M Low: $-104.42M High: $-10.27M avg. 27.91% | Avg: $-54.35M Low: $-60.99M High: $-48.17M avg. 42.17% | Avg: $25.39M Low: $22.50M High: $28.49M avg. 146.71% |
EBITDA
% change YoY
| $-78.00M N/A | $-77.85M 0.18% | $-66.41M 14.69% | Avg: $-77.76M Low: $-86.01M High: $-69.67M avg. -17.08% | Avg: $-122.62M Low: $-134.15M High: $-111.89M avg. -57.68% | Avg: $-187.59M Low: $-205.24M High: $-171.18M avg. -52.98% | Avg: $-361.41M Low: $-395.40M High: $-329.78M avg. -92.65% |
EPS
% change YoY
| -$0.14 N/A | -$0.83 -492.85% | -$1.09 -31.32% | Avg: -$0.95 Low: -$1.2 High: -$0.55 avg. 12.71% | Avg: -$0.77 Low: -$1.22 High: -$0.12 avg. 18.64% | Avg: -$0.64 Low: -$0.71 High: -$0.56 avg. 17.95% | Avg: $0.3 Low: $0.26 High: $0.33 avg. 146.71% |
Operating Expenses
% change YoY
| $117.15M N/A | $125.60M 7.21% | $135.54M 7.91% | Avg: $281.29M Low: $252.04M High: $311.15M avg. 107.53% | Avg: $443.57M Low: $404.76M High: $485.29M avg. 57.68% | Avg: $678.61M Low: $619.23M High: $742.43M avg. 52.98% | Avg: $1.30B Low: $1.19B High: $1.43B avg. 92.65% |
FAQ
What is Ocular Therapeutix stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 38.82% in 2025-2028.
We have gathered data from 7 analysts. Their low estimate is -102.71M, average is -130.38M and high is -47.07M.
What is Ocular Therapeutix stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 59.09% in 2025-2028.
We have gathered data from 6 analysts. Their low revenue estimate is $69.67M, average is $77.76M and high is $86.01M.
What is Ocular Therapeutix stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 49.00% in 2025-2028.
We have gathered data from 7 analysts. Their low earnings per share estimate is -$1.2, average is -$0.95 and high is $-0.55.
What is the best performing analyst?
In the last twelve months analysts have been covering Ocular Therapeutix stock. The most successful analyst is Biren Amin.